Evicenter
MarkdownMedical informationP&T meetings
Lysergide (DT120)

Generalized anxiety disorder

Also known as MM120
Launch
Not announced
Last updated
199 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Psychological therapies

10 evidence topics · 8 sources

CANMAT guideline: efficacy of CBT and other psychological treatments
Meta-analysis of psychotherapy and medication trials: 79 randomized trials

“Seventy-nine randomized controlled trials (RCT) including 11,002 participants with a diagnosis of GAD were included in a meta-analysis that tested the efficacy of psychotherapies or medications for GAD.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Consistent with prediction, evidence-based psychotherapies outperformed control conditions on primary outcome measures at posttreatment with a medium to large effect size (g = 0.76, 95% CI: 0.61–0.91, p < 0.001).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Within psychotherapy comparisons, pill placebo-controlled studies had the highest effect size (n = 3, g = 1.44, 95% CI: 0.94–1.94, p < 0.001), followed by WL controls (n = 22, g = 0.90, 95% CI: 0.73–1.08, p < 0.001), psychological placebo (n = 10, g = 0.47, 95% CI: 0.25–0.69, p < 0.001), and TAU (n = 5, g = 0.38, 95% CI: 0.05–0.71, p < 0.05;” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“There was evidence of publication bias in psychotherapy studies.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Because medication studies had more placebo control conditions than inactive conditions compared to psychotherapy studies, effect sizes between the domains should not be compared directly.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote